发明名称 Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution
摘要 PCT No. PCT/EP95/04401 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Nov. 9, 1995 PCT Pub. No. WO96/14830 PCT Pub. Date May 23, 1996Provided is a drug carrier comprising particles of at least one pure active compound which is insoluble, only sparingly soluble or moderately soluble in water, aqueous media and/or organic solvents, wherein said active ingredient is solid at room temperature and has an average diameter, determined by photon correlation spectroscopy (PCS) of 10 nm to 1,000 nm, the proportion of particles larger than 5 mu m in the total population being less than 0.1% (number distribution determined with a Coulter counter), and, when introduced into water, aqueous media and/or organic solvents, the active compound has an increased saturation solubility and an increased rate of dissolution compared with powders of the active compound prepared using an ultrasonic probe, a ball mill or a pearl mill, the solid particles having been comminuted, without prior conversion into a melt, by using cavitation or shearing and impact forces with introduction of a high amount of energy.
申请公布号 US5858410(A) 申请公布日期 1999.01.12
申请号 US19970836305 申请日期 1997.06.19
申请人 MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE 发明人 MULLER, RAINER H.;BECKER, ROBERT;KRUSS, BERND;PETERS, KATRIN
分类号 A61K9/107;A61K9/10;A61K9/14;A61K9/51;B01F17/56;B01J13/00;(IPC1-7):A61K9/14 主分类号 A61K9/107
代理机构 代理人
主权项
地址